Peptide library
HMG
Your guide to this compound.
Dose context
Individual prescription and exact product label; no catalog regimen defaults.
Dosing and preparation are indication- and presentation-specific. Use the linked prescribing information and the individual prescription; no generic dose range is assigned here.
How to read this information
Catalog ranges can describe approved labeling, clinical research or unverified reports. They are not interchangeable and do not select a personal dose.
Half-life
MENOPUR: the FSH component had an elimination half-life of 11–13 hours during the multiple-dose phase after SC or IM administration in pituitary-suppressed healthy premenopausal women. This does not assign a common half-life to every component, population or formulation; the labeled administration route is SC.
Species, route and formulation matter. Half-life does not define a safe dosing interval.
Routes and frequency in the catalog
No validated route or schedule recorded.
Storage
MENOPUR powder: 3–25°C until dispensed, protected from light. Use immediately after reconstitution; discard unused material.
Generic storage notes cannot establish a beyond-use date or sterility for a particular vial.
Preparation and reconstitution
Follow the exact presentation’s preparation instructions and supplied diluent. Do not transfer a mixing recipe from another brand or strength.